Douglas L. Arnold
McGill University(CA)
Publications by Year
Research Areas
Multiple Sclerosis Research Studies, Advanced MRI Techniques and Applications, Peripheral Neuropathies and Disorders, Polyomavirus and related diseases, Systemic Lupus Erythematosus Research
Most-Cited Works
- → B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis(2008)2,374 cited
- → Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis(2016)1,899 cited
- → Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis(2016)1,807 cited
- → Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis(2012)1,686 cited
- → Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial(2012)1,191 cited
- → Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial(2012)1,184 cited